anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

11,683-11,700 of 319,975

filter-aware
12
The data represents the percentage of respondents rating categories as '6' or '7' (very important).Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
13
The table uses a green highlight for the top 2 ranked criteria in the 2022 China column.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
14
The table highlights the 'Most influential position' in green for each column.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
15
Hospital Priorities 2022 China Edition: Strategic Implications for Pharma CompaniesHospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
16
Data derived from L.E.K. 2021, 2022 APAC Hospital Priorities Survey.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
17
Data from L.E.K. 2021, 2022 APAC Hospital Priorities Survey.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
18
Data derived from L.E.K. 2021 and 2022 APAC Hospital Priorities Survey.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
19
Data based on a survey of 120 respondents regarding sales representative outreach/presence.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
20
Data from L.E.K. 2022 APAC Hospital Priorities Survey.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
21
Hospital Priorities 2022 China Edition: Strategic Implications for Pharma CompaniesHospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
22
Data from L.E.K. 2021, 2022 APAC Hospital Priorities Survey.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
23
The slide uses a stacked bar chart to visualize survey data regarding hospital access restrictions for pharmaceutical sales representatives.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
24
The slide combines survey data on digital tool acceptance with epidemiological data on COVID-19 cases to justify the shift toward digital engagement.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
25
Survey data from 120 respondents in 2021 and 2022.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
26
Data based on a survey of 120 respondents.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
27
Hospital Priorities 2022 China Edition: Strategic Implications for Pharma CompaniesHospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Solution & Approach1 hit
28
The slide uses stacked bar charts to represent survey data on hospital financial health.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Solution & Approach1 hit
29
The slide uses a stacked bar chart for sustainability duration and a grouped bar chart for impact factors.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Solution & Approach1 hit